Back to Medicine Index

Febustat 40 mg

Tablet

Generic: Febuxostat

Incepta Pharmaceuticals Ltd.

Therapeutic Class: Anti-Gout (Xanthine Oxidase Inhibitor)

Indications

Treatment of chronic hyperuricaemia in patients with gout.

Pharmacology

Febuxostat is a non-purine selective inhibitor of xanthine oxidase. It reduces the production of uric acid and lowers the serum uric acid level.

Dosage & Administration

Adult: initially 40 mg once daily; if the serum uric acid remains above 6 mg/dl after 2 weeks, 80 mg once daily. May be taken with or without food. Not recommended for children.

Side Effects

Gout flares, abnormal liver function tests, nausea, diarrhoea, headache, joint pain and skin rash.

Precautions & Warnings

Gout flares may occur after starting treatment; prophylaxis with an NSAID or colchicine is recommended. Use with caution in patients with ischaemic heart disease or heart failure. Monitor liver function. Stop the medicine if a serious skin or allergic reaction occurs. Not recommended in pregnancy and breast-feeding.

Contraindications

Hypersensitivity to febuxostat. Concomitant use with azathioprine or mercaptopurine.

Storage Conditions

Store below 30°C in a cool, dry place, away from light. Keep out of the reach of children.

This information is for reference only. Always consult a qualified doctor or pharmacist before taking any medicine.